Total Payments
$466,619
2024 Payments
$44,385
Companies
17
Transactions
773
Medicare Patients
957
Medicare Billing
$99,397
Payment Breakdown by Category
Other$386,690 (82.9%)
Travel$40,823 (8.7%)
Consulting$25,623 (5.5%)
Food & Beverage$13,328 (2.9%)
Education$155.17 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $383,630 | 374 | 82.2% |
| Travel and Lodging | $40,823 | 161 | 8.7% |
| Consulting Fee | $25,623 | 12 | 5.5% |
| Food and Beverage | $13,328 | 212 | 2.9% |
| Honoraria | $3,060 | 2 | 0.7% |
| Education | $155.17 | 12 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $268,032 | 453 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70,627 | 108 | $0 (2023) |
| Novo Nordisk Inc | $70,450 | 81 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $19,483 | 48 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $14,604 | 21 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $8,918 | 21 | $0 (2019) |
| GENZYME CORPORATION | $7,320 | 10 | $0 (2017) |
| Horizon Therapeutics plc | $5,256 | 9 | $0 (2023) |
| Dexcom, Inc. | $676.51 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $361.13 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44,385 | 81 | Lilly USA, LLC ($42,365) |
| 2023 | $53,660 | 87 | Lilly USA, LLC ($41,093) |
| 2022 | $75,405 | 125 | Lilly USA, LLC ($67,463) |
| 2021 | $27,255 | 45 | Lilly USA, LLC ($25,675) |
| 2020 | $47,102 | 73 | Lilly USA, LLC ($38,954) |
| 2019 | $56,989 | 94 | Novo Nordisk Inc ($17,675) |
| 2018 | $78,061 | 129 | Lilly USA, LLC ($32,621) |
| 2017 | $83,762 | 139 | Boehringer Ingelheim Pharmaceuticals, Inc. ($39,494) |
All Payment Transactions
773 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Insulin Pump | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
| 09/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $139.70 | General |
| Category: Endocrinology | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $144.11 | General |
| Category: Endocrinology | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 04/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,225.00 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 229 | 305 | $95,940 | $24,298 |
| 2022 | 4 | 245 | 327 | $105,716 | $27,307 |
| 2021 | 4 | 250 | 354 | $109,640 | $30,774 |
| 2020 | 6 | 233 | 287 | $69,785 | $17,018 |
Total Patients
957
Total Services
1,273
Medicare Billing
$99,397
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 128 | 155 | $39,959 | $10,536 | 26.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 43 | 89 | $34,094 | $9,253 | 27.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 25 | 25 | $14,465 | $3,003 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 18 | $2,616 | $806.56 | 30.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 17 | 18 | $4,806 | $699.78 | 14.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 56 | 104 | $37,916 | $10,798 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 131 | 165 | $42,488 | $10,407 | 24.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 40 | 40 | $22,333 | $5,345 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 18 | 18 | $2,979 | $757.62 | 25.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 138 | 195 | $47,457 | $13,080 | 27.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 47 | 90 | $31,335 | $9,611 | 30.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 50 | 50 | $26,250 | $6,735 | 25.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 15 | 19 | $4,598 | $1,347 | 29.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 90 | 127 | $29,720 | $6,340 | 21.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 32 | 32 | $16,000 | $4,012 | 25.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 41 | 51 | $9,624 | $3,000 | 31.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 18 | 21 | $6,804 | $1,843 | 27.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 32 | 33 | $4,950 | $1,006 | 20.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 20 | 23 | $2,687 | $817.53 | 30.4% |
About Dr. Daniel Short, MD
Dr. Daniel Short, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in La Crosse, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376547257.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Short, MD has received a total of $466,619 in payments from pharmaceutical and medical device companies, with $44,385 received in 2024. These payments were reported across 773 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($383,630).
As a Medicare-enrolled provider, Short has provided services to 957 Medicare beneficiaries, totaling 1,273 services with total Medicare billing of $99,397. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location La Crosse, WI
- Active Since 06/09/2005
- Last Updated 05/23/2017
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1376547257
Products in Payments
- MOUNJARO (Drug) $137,040
- JARDIANCE (Drug) $97,871
- TRULICITY (Drug) $92,215
- Tresiba (Drug) $20,702
- INVOKANA (Drug) $19,477
- Ozempic (Drug) $12,579
- Victoza (Drug) $9,745
- Xultophy 100/3.6 (Drug) $8,841
- TZIELD (Biological) $7,479
- THYROGEN (Drug) $7,265
- SOTAGLIFLOZIN (Drug) $6,537
- TEPEZZA (Drug) $5,256
- STEGLATRO (Drug) $4,044
- JANUVIA (Drug) $2,234
- Rybelsus (Drug) $2,040
- RYBELSUS (Drug) $1,843
- FARXIGA (Drug) $361.13
- Dexcom G6 Transmitter (Medical Supply) $357.14
- Wegovy (Drug) $245.61
- TOUJEO (Drug) $238.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in La Crosse
Gregory Pehling, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $899.51
Endocrinology, Diabetes & Metabolism $899.51
Arnold Asp, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $562.39
Endocrinology, Diabetes & Metabolism $562.39
Madeline Fasen, Do, DO
Endocrinology, Diabetes & Metabolism — Payments: $443.33
Endocrinology, Diabetes & Metabolism $443.33
Jane Korducki, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $206.83
Endocrinology, Diabetes & Metabolism $206.83
Abigail Krueger, Do, DO
Endocrinology, Diabetes & Metabolism — Payments: $125.00
Endocrinology, Diabetes & Metabolism $125.00
Richard Reynertson, Md, MD
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism